insulin

Even with lawsuits and co-pay caps, will Insulin ever be affordable?

The sausage-making of how insulin is priced is not for the faint of heart. I’m a physician, not an economist. But the diagnosis seems plain as day: greed. More

The Insulin Wars

Insurance companies and drug manufacturers have come upon an ingenious business plan: They could farm out their dirty work to the doctors and the patients. When there’s an E. coli outbreak that causes illness and death, we rightly expect our regulatory bodies to step in. The outbreak of insulin greed is no different. More

Books by Danielle Ofri

Subscribe